RSV Immunisation

The HSE immunisation programme to protect new born babies against respiratory syncytial virus (RSV) will be available from September 1st 2025. Babies born between 1 September 2025 and February 2026 will be offered a monoclonal antibody immunisation, which is the best way to protect against RSV.

Respiratory syncytial virus (RSV) is a common virus that causes respiratory infection in children and adults. The risk of severe infection is highest in the youngest infants, especially those born during the RSV season in winter.

Among newborn babies in Ireland, each winter:

• 1 in 2 gets RSV - many need medical care from their GP or an emergency department (ED)
• 4 out of 100 are hospitalised due to RSV - some need special treatment in intensive care units

For further information please see the HSE's information leaflet here.